Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever

被引:27
作者
Yilmaz, Mustafa [1 ]
Aydin, Kemalettin [2 ]
Akdogan, Elif [1 ]
Sucu, Nurgun [2 ]
Sonmez, Mehmet [1 ]
Omay, Serdar Bedii [1 ]
Koksal, Iftihar [2 ]
机构
[1] Karadeniz Tech Univ, Sch Med, Dept Internal Med, Div Hematol, Trabzon, Turkey
[2] Karadeniz Tech Univ, Sch Med, Dept Clin Microbiol & Infect Dis, Trabzon, Turkey
关键词
Crimean-Congo hemorrhagic fever; mortality; natural killer cell;
D O I
10.1016/j.jcv.2008.03.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The relationship of changes in the peripheral blood lymphocyte subgroups during Crimean-Congo hemorrhagic fever (CCHF) to prognosis has not been reported. Objectives: To determine peripheral blood lymphocyte Subgroups in CCHF patients at the time of diagnosis and relate these to clinical outcome. Study Design: Peripheral blood samples were obtained from the patients treated at the Karadeniz Technical University Hospital for CCHF in 2004. Lymphocyte subgroups were analyzed by flow cytometry on these samples and their association with patients' risk group (severe vs. non-severe) and mortality was recorded. Results: There were significantly more peripheral blood natural killer (NK) cells in severe risk CCHF patients than in non-severe risk group CCHF patients. A positive correlation was found between NK cell count and aspartate transferase (AST), alanine transferase (ALT) and activated partial thromboplastin times (aPTT). In addition, NK cell counts were observed to be higher in two patients who died. Conclusion: Elevated NK cell counts may be a prognostic marker in CCHF patients. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 13 条
[1]  
ALTIKRITI SK, 1981, B WORLD HEALTH ORGAN, V59, P85
[2]   NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease [J].
Azeredo, EL ;
De Oliveira-Pinto, LM ;
Zagne, SM ;
Cerqueira, DIS ;
Nogueira, RMR ;
Kubelka, CF .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (02) :345-356
[3]   Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures [J].
Bakir, M ;
Ugurlu, M ;
Dokuzoguz, B ;
Bodur, H ;
Tasyaran, MA ;
Vahaboglu, H .
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (04) :385-389
[4]   Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited [J].
Ergonul, O. ;
Celikbas, A. ;
Baykam, N. ;
Eren, S. ;
Dokuzoguz, B. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (06) :551-554
[5]   Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy [J].
Ergönül, Ö ;
Çelikbas, A ;
Dokuzoguz, B ;
Eren, S ;
Baykam, N ;
Esener, H .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :284-287
[6]   Natural killer cells and viral infections [J].
French, AR ;
Yokoyama, WM .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) :45-51
[7]   Interleukin-15 as an activator of natural killer cell-mediated antiviral response [J].
Gosselin, J ;
Tomolu, A ;
Gallo, RC ;
Flamand, L .
BLOOD, 1999, 94 (12) :4210-4219
[9]   Crimean-Congo hemorrhagic fever in Turkey [J].
Karti, SS ;
Odabasi, Z ;
Korten, V ;
Yilmaz, M ;
Sonmez, M ;
Caylan, R ;
Akdogan, E ;
Eren, N ;
Koksal, I ;
Ovali, E ;
Erickson, BR ;
Vincent, MJ ;
Nichol, ST ;
Comer, JA ;
Rollin, PE ;
Ksiazek, TG .
EMERGING INFECTIOUS DISEASES, 2004, 10 (08) :1379-1384
[10]   Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy [J].
Ozkurt, Z ;
Kiki, H ;
Erol, S ;
Erdem, F ;
Yilmaz, N ;
Partak, M ;
Gundogdu, M ;
Tasyaran, MA .
JOURNAL OF INFECTION, 2006, 52 (03) :207-215